Hepatocyte nuclear factor 1 alpha and 4 alpha are factors involved in interindividual variability in the expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in human livers

被引:35
作者
Aueviriyavit, Sasitorn [1 ]
Furihata, Tomomi [1 ]
Morimoto, Kaori [1 ]
Kobayashi, Kaoru [1 ]
Chiba, Kan [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Pharmacol & Toxicol, Chuo Ku, Chiba 2608675, Japan
关键词
uDP-glucuronosyltransferase; hepatocyte nuclear factor; gene regulation; interindividual variability; human liver;
D O I
10.2133/dmpk.22.391
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferases (UGTs) catalyzephase-II biotransformation reaction of a variety of substances. Among the UGT1A isoforms, UGT1A1, UGT1A3, UGT1A4, UGT1A6 and UGT1A9 are predominantly expressed in the liver. Interindividual variability in expression of these isoforms would cause interindividual differences in drug response, toxicity and cancer susceptibility. In the present study, we investigated the interindividual variability in UGT1A mRNA expression and whether hepatocyte nuclear factor 1 alpha (HNF1 alpha) and HNF4 alpha were factors responsible for their variability in human livers. The amounts of UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, HNF1a and HNF4a mRNA in 18 human livers were measured by quantitative real-time polymerase chain reaction. The largest and smallest interindividual differences in expression levels were observed in UGT1A1 (8.6-fold) and UGT1A4 (2.5-fold) mRNA, respectively. The amounts of HNF1a and HNF4a mRNA were strongly correlated with the amount of UGT1A9 mRNA and moderately correlated with that of UGT1A6 mRNA, whereas no significant correlation was found with the amounts of UGT1A1, UGT1A3 and UGT1A4 mRNA. Our results suggest that HNF1a and HNF4a are the factors involved in the interindividual variability of UGT1A6 and UGT1A9 mRNA expression. Further studies of other transcription factors are needed to clarify the factor(s) determining the interindividual variations in UGT1A1, UGT1A3 and UGT1A4 mRNA expression.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 29 条
[21]  
RITTER JK, 1992, J BIOL CHEM, V267, P3257
[22]   Liver-enriched transcription factors in liver function and development. Part I: The hepatocyte nuclear factor network and liver-specific gene expression [J].
Schrem, H ;
Klempnauer, J ;
Borlak, J .
PHARMACOLOGICAL REVIEWS, 2002, 54 (01) :129-158
[23]   Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor α activation [J].
Senekeo-Effenberger, Kathy ;
Chen, Shujuan ;
Brace-Sinnokrak, Erin ;
Bonzo, Jessica A. ;
Yueh, Mei-Fei ;
Argikar, Upendra ;
Kaeding, Jenny ;
Trottier, Jocelyn ;
Remmel, Rory P. ;
Ritter, Joseph K. ;
Barbier, Olivier ;
Tukey, Robert H. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) :419-427
[24]  
Strassburg CP, 1997, CANCER RES, V57, P2979
[25]   TISSUE-SPECIFIC EXPRESSION OF THE GENE ENCODING HEPATOCYTE NUCLEAR FACTOR-I MAY INVOLVE HEPATOCYTE NUCLEAR FACTOR-IV [J].
TIAN, JM ;
SCHIBLER, U .
GENES & DEVELOPMENT, 1991, 5 (12A) :2225-2234
[26]   Hepatocyte nuclear factor-1α is a causal factor responsible for interindividual differences in the expression of UDP-glucuronosyltransferase 2B7 mRNA in human livers [J].
Toide, K ;
Takahashi, Y ;
Yamazaki, H ;
Terauchi, Y ;
Fujii, T ;
Parkinson, A ;
Kamataki, T .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (06) :613-615
[27]   Human UDP-glucuronosyltransferases: Metabolism, expression, and disease [J].
Tukey, RH ;
Strassburg, CP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :581-616
[28]   Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes [J].
Vandesompele, Jo ;
De Preter, Katleen ;
Pattyn, Filip ;
Poppe, Bruce ;
Van Roy, Nadine ;
De Paepe, Anne ;
Speleman, Frank .
GENOME BIOLOGY, 2002, 3 (07)
[29]   Glucuronidation and the UDP-glucuronosyltransferases in health and disease [J].
Wells, PG ;
Mackenzie, PI ;
Chowdhury, JR ;
Guillemette, C ;
Gregory, PA ;
Ishii, Y ;
Hansen, AJ ;
Kessler, FK ;
Kim, PM ;
Chowdhury, NR ;
Ritter, JK .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (03) :281-290